The METTL14 loci carried synaptopodin 2 (SYNPO2), where a mutation looped between the first intron of this gene and the METTL14 promotor was linked to increased susceptibility to ovarian cancers in humans (Figure 4B) [43]. This evidence concerns the gene SYNPO2 and ovarian carcinoma.